Form 4 Filing for CEL SCI CORP (CVM)

This filing details a Form 4 submission for CEL SCI CORP (CVM) concerning derivative security transactions. Robert Eugene Watson, a director, acquired 110,000 options on August 14, 2026, with a transaction price of $0.01 per share. These options, exercisable at $1.49, vest in three equal annual installments starting one year after the grant date. The options are for CEL SCI CORP Common Stock and expire on August 13, 2036. Following this transaction, Mr. Watson directly owns 137,271 shares.